Clinical Trial Update: Comparative Quantification of MTX and Its Metabolites Post Glucarpidase

View source ↗

Summary

This completed clinical trial evaluated the pharmacokinetics of methotrexate and its metabolites after glucarpidase administration in patients with lymphoma or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoma

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Voraxaze (glucarpidase)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Lymphoma, Acute Lymphatic Leukemia | Status: COMPLETED